$MVIS
MICROVISION, INC. Stock $mvis

$mvis Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000119312523056723 Filed on March 02, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$782.0K	$0.00	$350.0K
YoY Change	123.43%	-100.0%	-27.08%
Cost Of Revenue	$544.0K	-$11.00K	$4.000K
YoY Change	13500.0%	-122.92%	-140.0%
Gross Profit	$238.0K	-$33.00K	$346.0K
YoY Change	-31.21%	-106.48%	-27.92%
Gross Profit Margin	30.43%		98.86%
Selling, General & Admin	$8.737M	$6.377M	$5.877M
YoY Change	48.66%	-4.08%	161.2%
% of Gross Profit	3671.01%		1698.55%
Research & Development	$12.69M	$7.585M	$7.593M
YoY Change	67.15%	17.02%	70.25%
% of Gross Profit	5332.77%		2194.51%
Depreciation & Amortization	$2.524M	$821.0K	$483.0K
YoY Change	422.57%	93.63%	61.0%
% of Gross Profit	1060.5%		139.6%
Operating Expenses	$21.43M	$13.96M	$13.47M
YoY Change	59.09%	6.34%	100.75%
Operating Profit	-$21.19M	-$13.99M	-$13.12M
YoY Change	61.47%	10.89%	110.66%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$639.0K	$520.0K	-$44.00K
YoY Change	-1552.27%	-13100.0%	340.0%
Pretax Income	-$18.85M	-$13.48M	-$13.17M
YoY Change	43.12%	6.73%	111.36%
Income Tax	$181.0K		$0.00
% Of Pretax Income
Net Earnings	-$19.03M	-$13.48M	-$13.17M
YoY Change	44.49%	6.73%	111.36%
Net Earnings / Revenue	-2433.12%		-3762.29%
Basic Earnings Per Share	-$0.11	-$0.08	-$0.08
Diluted Earnings Per Share	-$0.11	-$0.08	-$80.02K
COMMON SHARES
Basic Shares Outstanding	175.8M	166.0M shares	164.6K
Diluted Shares Outstanding	174.7K		164.6K

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$63.04M	$82.71M	$103.3M
YoY Change	-38.95%	-28.31%	37.06%
Cash & Equivalents	$18.50M	$20.54M	$55.61M
Short-Term Investments	$44.54M	$62.17M	$47.65M
Other Short-Term Assets	$2.182M	$2.306M	$1.865M
YoY Change	17.0%	1.01%	227.19%
Inventory	$3.116M	$1.861M	$1.815M
Prepaid Expenses
Receivables	$506.0K	$4.132M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$76.99M	$91.01M	$106.9M
YoY Change	-28.01%	-23.8%	40.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.28M	$6.830M	$8.616M
YoY Change	19.36%	125.71%	177.94%
Goodwill
YoY Change
Intangibles	$19.00M	$75.00K
YoY Change		-34.78%
Long-Term Investments
YoY Change
Other Assets	$2.242M	$2.504M	$2.106M
YoY Change	6.46%	20.56%	357.83%
Total Long-Term Assets	$46.27M	$23.99M	$10.83M
YoY Change	327.38%	122.21%	191.83%
TOTAL ASSETS
Total Short-Term Assets	$76.99M	$91.01M	$106.9M
Total Long-Term Assets	$46.27M	$23.99M	$10.83M
Total Assets	$123.3M	$115.0M	$117.8M
YoY Change	4.66%	-11.69%	47.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.629M	$2.061M	$1.919M
YoY Change	89.11%	-42.49%	174.14%
Accrued Expenses	$4.223M	$2.058M	$1.974M
YoY Change	113.93%	75.9%	42.01%
Deferred Revenue	$5.676M	$4.601M
YoY Change		-12.61%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$15.00K	$21.00K	$122.0K
YoY Change	-87.7%	-94.92%	-83.29%
Total Short-Term Liabilities	$22.16M	$11.43M	$9.404M
YoY Change	135.59%	-8.31%	-6.89%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$15.00K
YoY Change	-100.0%	-100.0%	-98.39%
Other Long-Term Liabilities	$17.00K	$13.83M	$4.882M
YoY Change	-99.65%	177.52%	687.42%
Total Long-Term Liabilities	$17.00K	$13.83M	$4.897M
YoY Change	-99.65%	176.08%	215.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.16M	$11.43M	$9.404M
Total Long-Term Liabilities	$17.00K	$13.83M	$4.897M
Total Liabilities	$36.72M	$25.26M	$14.30M
YoY Change	156.79%	44.55%	22.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$701.6M	-$682.5M
YoY Change		8.43%
Common Stock	$176.0K	$171.0K
YoY Change		4.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$86.54M	$89.74M	$103.5M
YoY Change
Total Liabilities & Shareholders Equity	$123.3M	$115.0M	$117.8M
YoY Change	4.66%	-11.69%	47.93%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$19.03M	-$13.48M	-$13.17M
YoY Change	44.49%	6.73%	111.36%
Depreciation, Depletion And Amortization	$2.524M	$821.0K	$483.0K
YoY Change	422.57%	93.63%	61.0%
Cash From Operating Activities	-$13.48M	-$8.403M	-$10.91M
YoY Change	23.61%	2.99%	140.77%
INVESTING ACTIVITIES
Capital Expenditures	$615.0K	$2.342M	-$884.0K
YoY Change	-169.57%	-610.24%	55.09%
Acquisitions	$11.23M		$0.00
YoY Change
Other Investing Activities	$6.869M	-$4.688M	-$15.20M
YoY Change	-145.2%	-85.72%
Cash From Investing Activities	$6.254M	-$7.030M	-$16.08M
YoY Change	-138.89%	-78.88%	2721.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net	$0.00		$294.0K
YoY Change	-100.0%
Cash From Financing Activities	12.69M	13.99M	-49.00K
YoY Change	-25987.76%	-3706.19%	-100.08%
NET CHANGE
Cash From Operating Activities	-13.48M	-8.403M	-10.91M
Cash From Investing Activities	6.254M	-7.030M	-16.08M
Cash From Financing Activities	12.69M	13.99M	-49.00K
Net Change In Cash	5.457M	-1.441M	-27.04M
YoY Change	-120.18%	-96.56%	-146.24%
FREE CASH FLOW
Cash From Operating Activities	-$13.48M	-$8.403M	-$10.91M
Capital Expenditures	$615.0K	$2.342M	-$884.0K
Free Cash Flow	-$14.10M	-$10.74M	-$10.02M
YoY Change	40.65%	39.55%	153.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	mvis	Noncash Interest Income Expenses NoncashInterestIncomeExpenses	0
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000065770
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-34170
CY2022	dei	Entity Registrant Name EntityRegistrantName	MicroVision, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1600822
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	18390 NE 68th Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Redmond
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98052
CY2022	dei	City Area Code CityAreaCode	425
CY2022	dei	Local Phone Number LocalPhoneNumber	936-6847
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	MVIS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	635300000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	175818617
CY2022	dei	Auditor Firm AuditorFirmId	659
CY2022	dei	Auditor Name AuditorName	Moss Adams LLP
CY2022	dei	Auditor Location AuditorLocation	Seattle, Washington
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20536000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82647000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	62173000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	32720000
CY2022Q4	us-gaap	Inventory Net InventoryNet	1861000
CY2021Q4	us-gaap	Inventory Net InventoryNet	1780000
CY2022Q4	mvis	Asset Acquisition Consideration Transferred Asset Current AssetAcquisitionConsiderationTransferredAssetCurrent	4132000
CY2021Q4	mvis	Asset Acquisition Consideration Transferred Asset Current AssetAcquisitionConsiderationTransferredAssetCurrent	0
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2306000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2283000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	91008000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	119430000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6830000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3026000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14579000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5577000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	1418000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	1092000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	75000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	115000
CY2022Q4	us-gaap	Other Assets OtherAssets	1086000
CY2021Q4	us-gaap	Other Assets OtherAssets	985000
CY2022Q4	us-gaap	Assets Assets	114996000
CY2021Q4	us-gaap	Assets Assets	130225000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2061000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3584000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2058000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1170000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4601000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5265000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	839000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1181000
CY2022Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	0
CY2021Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	392000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1846000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	849000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	21000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	21000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11426000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12462000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13829000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4983000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	26000
CY2022Q4	us-gaap	Liabilities Liabilities	25255000
CY2021Q4	us-gaap	Liabilities Liabilities	17471000
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	210000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	210000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170503000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170503000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	164363000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	164363000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	171000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	164000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	772221000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	742042000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-127000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-682524000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-629433000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	89741000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	112754000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	114996000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	130225000
CY2022	us-gaap	Revenues Revenues	664000
CY2021	us-gaap	Revenues Revenues	2500000
CY2020	us-gaap	Revenues Revenues	3090000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	100000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	2000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	1398000
CY2022	us-gaap	Gross Profit GrossProfit	564000
CY2021	us-gaap	Gross Profit GrossProfit	2498000
CY2020	us-gaap	Gross Profit GrossProfit	1692000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30413000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24111000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9840000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24041000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22256000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5917000
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	450000
CY2022	us-gaap	Operating Expenses OperatingExpenses	54454000
CY2021	us-gaap	Operating Expenses OperatingExpenses	46367000
CY2020	us-gaap	Operating Expenses OperatingExpenses	15307000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-53890000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-43869000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-13615000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	692000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	799000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-23000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53091000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43200000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13634000
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.1
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165958
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165958
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160662
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	160662
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139829
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139829
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53091000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43200000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13634000
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	108000
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	19000
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53199000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43219000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13634000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-3977000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	1252000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24368000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13634000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9009000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	15284000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2654000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	129026000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43200000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	112754000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	15461000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	726000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13999000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53091000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-108000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	89741000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53091000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43200000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13634000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2246000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1464000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	963000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	64000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	882000
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	450000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	15461000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	15284000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1297000
CY2021	mvis	Noncash Interest Income Expenses NoncashInterestIncomeExpenses	-10000
CY2020	mvis	Noncash Interest Income Expenses NoncashInterestIncomeExpenses	11000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	87000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	48000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	168000
CY2022	mvis	Net Accretion Of Premium On Shortterm Investments NetAccretionOfPremiumOnShorttermInvestments	21000
CY2021	mvis	Net Accretion Of Premium On Shortterm Investments NetAccretionOfPremiumOnShorttermInvestments	86000
CY2020	mvis	Net Accretion Of Premium On Shortterm Investments NetAccretionOfPremiumOnShorttermInvestments	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	692000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1079000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	168000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1828000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-24000
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	217000
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2552000
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-154000
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1737000
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2520000
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1387000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	888000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	675000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1550000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-21000
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-293000
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1319000
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2073000
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1280000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-762000
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-656000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38019000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29404000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16075000
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	60576000
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	90158000
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	32825000
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0
CY2022	mvis	Payments To Acquire Assets PaymentsToAcquireAssets	4132000
CY2021	mvis	Payments To Acquire Assets PaymentsToAcquireAssets	0
CY2020	mvis	Payments To Acquire Assets PaymentsToAcquireAssets	0
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	525000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4359000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2493000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	402000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38073000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35318000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	123000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	26000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	28000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	29000
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1571000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	392000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	488000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0
CY2021	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	6135000
CY2020	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	726000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2654000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13999000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	122891000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	24435000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14307000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	131164000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	26977000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-61785000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	66442000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11025000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83739000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17297000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6272000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21954000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83739000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17297000
CY2022	mvis	Issuance Of Common Stock For Subscriptions Receivable IssuanceOfCommonStockForSubscriptionsReceivable	0
CY2021	mvis	Issuance Of Common Stock For Subscriptions Receivable IssuanceOfCommonStockForSubscriptionsReceivable	0
CY2020	mvis	Issuance Of Common Stock For Subscriptions Receivable IssuanceOfCommonStockForSubscriptionsReceivable	6135000
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0
CY2020	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	70000
CY2022	mvis	Lease Liabilities From Obtaining Rightofuse Operating Asset LeaseLiabilitiesFromObtainingRightofuseOperatingAsset	10184000
CY2021	mvis	Lease Liabilities From Obtaining Rightofuse Operating Asset LeaseLiabilitiesFromObtainingRightofuseOperatingAsset	5097000
CY2020	mvis	Lease Liabilities From Obtaining Rightofuse Operating Asset LeaseLiabilitiesFromObtainingRightofuseOperatingAsset	0
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	764000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	550000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	116000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20536000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82647000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16862000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	1418000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	1092000
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	435000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21954000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83739000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17297000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18500000
CY2023Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	59200000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Use of estimates </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with generally accepted accounting principles of the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from our estimates. We have identified the following areas where estimates and assumptions have been made in preparing the financial statements: revenue recognition, inventory valuation, valuation of share-based payments, income taxes, depreciable lives assessment and related disclosure of contingent assets and liabilities. </div></div>
CY2022Q4	mvis	Letter Of Credit For Future Lease LetterOfCreditForFutureLease	657000
CY2022Q4	mvis	Letter Of Credit For Current Lease LetterOfCreditForCurrentLease	305000
CY2022Q4	mvis	Letter Of Credit For Past Lease LetterOfCreditForPastLease	457000
CY2022	mvis	Revenue Recognition Services License And Royalty RevenueRecognitionServicesLicenseAndRoyalty	<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">License and royalty revenue </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We recognize revenue on upfront license fees at a point in time if the nature of the license granted is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-to-use</div></div> license, representing functional intellectual property with significant standalone functionality. If the nature of the license granted is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-to-access</div></div> license, representing symbolic intellectual property, which excludes significant standalone functionality, we recognize revenue over the period of time we have ongoing obligations under the agreement. We will recognize revenue from sales-based royalties on the basis of the quarterly reports provided by our customer as to the number of royalty-bearing products sold or otherwise distributed. In the event that reports are not received, we will estimate the number of royalty-bearing products sold by our customers. </div>
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022	mvis	Revenue Recognition Services Cost Of Contract Revenue RevenueRecognitionServicesCostOfContractRevenue	<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cost of contract revenue </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of contract revenue includes both the direct and allocated indirect costs of performing on contracts and producing prototype units and evaluation kits based on our PicoP<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">®</div> scanning module. Direct costs include labor, materials and other costs incurred directly in producing prototype units and evaluation kits or performing on a contract. Indirect costs include labor and other costs associated with operating our research and development department and building our technical capabilities and capacity. Cost of contract revenue is determined by the level of direct and indirect costs incurred, which can fluctuate substantially from period to period. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our overhead, which includes the costs of procuring, inspecting and storing material, and facility and depreciation costs, is allocated to inventory, cost of product revenue, cost of contract revenue, and research and development expense based on the level of effort supporting production or research and development activity.</div></div>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of credit risk and major customers and suppliers </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of credit risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject us to a concentration of credit risk are primarily cash equivalents and accounts receivable. We typically do not require collateral from our customers. As of December 31, 2022, our cash and cash equivalents are comprised of short-term highly rated (A rated securities and above) money market savings accounts. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of major customers and suppliers </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In 2022 one customer, Microsoft Corporation, accounted for $664,000 in revenue, representing 100% of our total revenue. In 2021, the same customer accounted for $2.5 million in revenue, representing 100% of our total revenue. In 2020, the same customer accounted for $3.0 million in revenue, representing 97% of our total revenue. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Typically, a significant concentration of our components and the products we have sold are manufactured and obtained from single or limited-source suppliers. The loss of any single or limited-source supplier, the failure of any of these suppliers to perform as expected, or the disruption in the supply chain of components from these suppliers could subject us to risks and uncertainties including, but not limited to, increased cost of sales, possible loss of revenues, or significant delays in product development or product deliveries, any of which could adversely affect our financial condition and operating results. </div></div>
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-53091000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-43200000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13634000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165958
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165958
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160662
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	160662
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139829
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139829
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2500000
CY2020	mvis	Timing Of Revenue Recognition TimingOfRevenueRecognition	Timing of revenue recognition:
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.1
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9811
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4158
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5263
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	15461000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	15284000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1297000
CY2022	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Reclassifications </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. These reclassifications had no impact on net loss, shareholders’ equity or cash flows, as previously reported. </div></div>
CY2022	mvis	Timing Of Revenue Recognition TimingOfRevenueRecognition	Timing of revenue recognition
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	664000
CY2021	mvis	Timing Of Revenue Recognition TimingOfRevenueRecognition	Timing of revenue recognition:
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3090000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4601000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5265000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7765000
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2022	mvis	Contract With Customer Asset Net Current Change ContractWithCustomerAssetNetCurrentChange	0
CY2022	mvis	Contract With Customer Asset Net Current Percent Change ContractWithCustomerAssetNetCurrentPercentChange	0
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4601000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5265000
CY2022	mvis	Contract With Customer Liability Current Change ContractWithCustomerLiabilityCurrentChange	664000
CY2022	mvis	Contract With Customer Liability Current Percent Change ContractWithCustomerLiabilityCurrentPercentChange	12.6
CY2022Q4	mvis	Contract With Customer Assetand Liabilities Net ContractWithCustomerAssetandLiabilitiesNet	-4601000
CY2021Q4	mvis	Contract With Customer Assetand Liabilities Net ContractWithCustomerAssetandLiabilitiesNet	-5265000
CY2022	mvis	Contract With Customer Assetand Liabilities Net Change ContractWithCustomerAssetandLiabilitiesNetChange	664000
CY2022	mvis	Contract With Customer Assetand Liabilities Net Percent Change ContractWithCustomerAssetandLiabilitiesNetPercentChange	12.6
CY2022Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	0
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	62300000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	129000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	62173000
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	32739000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	22000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	32720000
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	62300000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	62173000
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	32739000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	32720000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	46825000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	129000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	46825000
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	129000
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	27195000
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	22000
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	27195000
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	22000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1556000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1780000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	305000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	0
CY2022Q4	us-gaap	Inventory Net InventoryNet	1861000
CY2021Q4	us-gaap	Inventory Net InventoryNet	1780000
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	87000
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	48000
CY2020	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	168000
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	537000
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	43000
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	766000
CY2021Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	601000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	378000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	89000
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	130000
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	263000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	247000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	174000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2058000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1170000
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6140000
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	8224000
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3789000
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	913000
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	10515000
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	7230000
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1804000
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1372000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22248000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17739000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15418000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14713000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6830000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3026000
CY2022	us-gaap	Depreciation Depreciation	705000
CY2021	us-gaap	Depreciation Depreciation	902000
CY2020	us-gaap	Depreciation Depreciation	442000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	951000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	951000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	32000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	22000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	75000
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	43500000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	12700000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1.20
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1.11
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	9180000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2460
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1391000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	9160
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1548000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.009
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.003
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	mvis	Prevest Forfeiture Rate PrevestForfeitureRate	0
CY2021	mvis	Prevest Forfeiture Rate PrevestForfeitureRate	0.085
CY2020	mvis	Prevest Forfeiture Rate PrevestForfeitureRate	0.085
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	11.72
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.2
CY2022	mvis	Total Grant Date Fair Value Of Options Vested TotalGrantDateFairValueOfOptionsVested	115000
CY2021	mvis	Total Grant Date Fair Value Of Options Vested TotalGrantDateFairValueOfOptionsVested	508000
CY2020	mvis	Total Grant Date Fair Value Of Options Vested TotalGrantDateFairValueOfOptionsVested	604000
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1000
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M12D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1215000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	400
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1462000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1080.00
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	219000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	880
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	475000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	770
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1983000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	760
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	4179000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12920
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	2380000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3110
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1157000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	11970
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2625000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	13050.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	6420
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8866000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3850
CY2022	us-gaap	Lessee Finance Lease Description LesseeFinanceLeaseDescription	Our finance leases contain options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless we are reasonably certain to exercise the purchase option.
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	9300000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1501000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	513000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	464000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	26000
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	30000
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	26000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3000
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3000
CY2022	mvis	Total Finance Lease Expense TotalFinanceLeaseExpense	28000
CY2021	mvis	Total Finance Lease Expense TotalFinanceLeaseExpense	33000
CY2020	mvis	Total Finance Lease Expense TotalFinanceLeaseExpense	29000
CY2022	us-gaap	Lease Cost LeaseCost	1529000
CY2021	us-gaap	Lease Cost LeaseCost	546000
CY2020	us-gaap	Lease Cost LeaseCost	493000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1280000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	762000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	656000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	2000
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3000
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	26000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	28000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	29000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10184000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5322000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14579000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5577000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	21000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	47000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y1M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y6M
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y6M
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.025
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.063
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.063
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1904000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	22000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	1896000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	1947000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	2000000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	11642000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	19389000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	22000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3714000
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	15675000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	21000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.005
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.082
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.022
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.251
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.09
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.162
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.475
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.015
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.014
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.022
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.108
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.231
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.243
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	651000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	634000
CY2022Q3	us-gaap	Gross Profit GrossProfit	-45000
CY2022Q2	us-gaap	Gross Profit GrossProfit	296000
CY2022Q1	us-gaap	Gross Profit GrossProfit	346000
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-13475000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12851000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-13597000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	92469000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	90593000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	9628000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	8984000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	19787000
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	17417000
CY2022Q4	mvis	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	3292000
CY2021Q4	mvis	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	1222000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	7360000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	6701000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	133187000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	125551000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	3062000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	1171000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3062000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1171000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	130125000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	124380000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2022	us-gaap	Other Information Pertaining To Income Taxes OtherInformationPertainingToIncomeTaxes	During 2022, $22.0 million federal net operating losses and $171,000 general business credits expired unused.
CY2022	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	In certain circumstances, as specified in the Internal Revenue Code, a 50% or more ownership change by certain combinations of our shareholders during any three year period would result in limitations on our ability to use a portion of our net operating loss carryforwards.
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2020	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2022	us-gaap	Open Tax Year OpenTaxYear	1998
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	411000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	259000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	213000
CY2022Q4	us-gaap	Revenues Revenues	0
CY2022Q3	us-gaap	Revenues Revenues	0
CY2022Q2	us-gaap	Revenues Revenues	314000
CY2022Q1	us-gaap	Revenues Revenues	350000
CY2022Q4	us-gaap	Gross Profit GrossProfit	-33000
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13168000
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q4	us-gaap	Revenues Revenues	557000
CY2021Q3	us-gaap	Revenues Revenues	718000
CY2021Q2	us-gaap	Revenues Revenues	746000
CY2021Q1	us-gaap	Revenues Revenues	479000
CY2021Q4	us-gaap	Gross Profit GrossProfit	509000
CY2021Q3	us-gaap	Gross Profit GrossProfit	728000
CY2021Q2	us-gaap	Gross Profit GrossProfit	777000
CY2021Q1	us-gaap	Gross Profit GrossProfit	484000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-12625000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9382000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14962000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6231000
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2020Q4	us-gaap	Revenues Revenues	395000
CY2020Q3	us-gaap	Revenues Revenues	639000
CY2020Q2	us-gaap	Revenues Revenues	587000
CY2020Q1	us-gaap	Revenues Revenues	1469000
CY2020Q4	us-gaap	Gross Profit GrossProfit	395000
CY2020Q3	us-gaap	Gross Profit GrossProfit	639000
CY2020Q2	us-gaap	Gross Profit GrossProfit	588000
CY2020Q1	us-gaap	Gross Profit GrossProfit	70000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-3570000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-2826000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-2304000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-4934000
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	117725000
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	0
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-3318000
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	114407000
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	114407000
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	9973000
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	124380000
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	124380000
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	5745000
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	130125000

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001193125-23-056723-index-headers.html	Edgar Link	pending
0001193125-23-056723-index.html	Edgar Link	pending
0001193125-23-056723.txt	Edgar Link	pending
0001193125-23-056723-xbrl.zip	Edgar Link	pending
d461483d10k.htm	Edgar Link	pending
d461483dex109.htm	Edgar Link	pending
d461483dex231.htm	Edgar Link	pending
d461483dex311.htm	Edgar Link	pending
d461483dex312.htm	Edgar Link	pending
d461483dex321.htm	Edgar Link	pending
d461483dex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g461483g0228043938413.jpg	Edgar Link	pending
g461483g0228043938538.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mvis-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
mvis-20221231_cal.xml	Edgar Link	unprocessable
mvis-20221231_def.xml	Edgar Link	unprocessable
mvis-20221231_lab.xml	Edgar Link	unprocessable
mvis-20221231_pre.xml	Edgar Link	unprocessable
d461483d10k_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MVIS
MICROVISION, INC. Stock $mvis

2023 Q1 Form 10-K Financial Statement

#000119312523056723 Filed on March 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVIS MICROVISION, INC. Stock $mvis

2023 Q1 Form 10-K Financial Statement

#000119312523056723 Filed on March 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVIS
MICROVISION, INC. Stock $mvis